| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/1999 | US5858714 Human metaxin protein |
| 01/12/1999 | US5858713 Calcium permeable insect sodium channels and use thereof |
| 01/12/1999 | US5858712 CDNA encoding a LEA-motif developmental protein homologous to avian px19 |
| 01/12/1999 | US5858711 Nucleotide sequence coding for protein which interacts with nuclear factor of activated t cell family of proteins to affect immune system response; for assays to determine modulation of protein activity |
| 01/12/1999 | US5858710 Tumor-associated kazal inhibitor-like polypeptides and encoding polynucleotides |
| 01/12/1999 | US5858709 Fibronectin binding protein B compounds |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858707 Nucleic acids coding for polypeptides which are structurally homologous to prokaryotic nucleoside transporters; anticancer agents; antiproliferative agents; developmental disorders |
| 01/12/1999 | US5858702 Dna from salivary, lacrimal, and pulmonary tissues; therapy for cystic fibrosis/sjogrens syndrome |
| 01/12/1999 | US5858701 DNA encoding an insulin receptor substrate |
| 01/12/1999 | US5858689 Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof |
| 01/12/1999 | US5858688 Gro genes, proteins, and uses thereof |
| 01/12/1999 | US5858686 Methods for detecting tyrosine kinase-binding target proteins and identifying substances that affect SH2 phosphorylated ligand regulatory systems |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/12/1999 | US5858679 Detecting tumor suppressor gene by measuring ionizing radiation induced expression of a growth-arrest, dna damage inducible protein in stimulated/unstimulated mammalian cells |
| 01/12/1999 | US5858678 Isolated poypetides which interact with e1b 19kd protein, bcl-2 protein and/or bhrf-1 protein, all associated with cell death; alzheimers disease, spina bifida |
| 01/12/1999 | US5858677 Protein D--an IgD-binding protein of haemophilus influenzae |
| 01/12/1999 | US5858675 Double-stranded RNA-binding protein |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858672 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (CAEV) genome, and uses thereof |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858669 Beclin, a novel bcl-2 interacting gene near BRCA1 on chromosome 17q21 and methods of use |
| 01/12/1999 | US5858665 Nucleic acid hybridization using two-stage target cyclingreaction involving probe-activator complexes and analog-anchor complexes, kits with increase sensitivity |
| 01/12/1999 | US5858663 Detecting presence of chromosome8-chromosome-21 translocation by contacting sample rna with nucleic acid probes/primers, detecting hybridization; diagnosis of acute myelogenous leukemia |
| 01/12/1999 | US5858662 Determining zygosity of individual by hybridization of nucleic acid probe or primer to sample; hemizygosity is indicator of impaired visuospatial constructive cognition |
| 01/12/1999 | US5858661 Isolation, purification, cloned nucleic acid sequence with mutation causing protein truncation or no initiation; detecting carriers by analysis of nucleic acids isolated from patients with hereditary muscular disorders |
| 01/12/1999 | US5858660 Parallel selex |
| 01/12/1999 | US5858655 Quantitative analysis by nucleic acid hybridization using oligonucleotide probes from gene; detection of breast cancer, lymphoma, squamous cell cancer and parathyroid adenoma |
| 01/12/1999 | US5858651 Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes |
| 01/12/1999 | US5858647 Detecting binding of purified or isolated antigen of hiv-1 subtype o virus to antibodies present in biological sample, comparing to control; diagnosis of infection, aids, and aids related complex; kits |
| 01/12/1999 | US5858646 Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858369 Anti-acids secretory recombinant BCG vaccine |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/12/1999 | US5858367 Methods for screening for antimicrobials utilizing AarC and compositions thereof |
| 01/12/1999 | US5858366 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
| 01/12/1999 | US5858364 Orally or enterally administering myelin |
| 01/12/1999 | US5858362 Polysaccharide-protein |
| 01/12/1999 | US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma |
| 01/12/1999 | US5858358 Methods for selectively stimulating proliferation of T cells |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858353 Insect viruses, sequences, insecticidal compositions and methods |
| 01/12/1999 | US5858351 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| 01/12/1999 | US5858347 Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors |
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/12/1999 | CA2110917C Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 01/12/1999 | CA2070503C A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 01/12/1999 | CA1340317C Atrial natriuretic factor |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/10/1999 | CA2209815A1 Vaccine method using osmotic pump |
| 01/09/1999 | CA2237158A1 Human semaphorin l (h-semal) and corresponding semaphorins in other species |
| 01/09/1999 | CA2205881A1 Tcr scfv and biological applications thereof |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000673A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | WO1999000518A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | WO1999000516A2 Neuronal stem cell gene |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000504A1 Improved protein expression strains |
| 01/07/1999 | WO1999000503A1 Method of increasing fruit size in a plant |
| 01/07/1999 | WO1999000502A1 Seed plants characterized by delayed seed dispersal |
| 01/07/1999 | WO1999000501A1 Materials and methods relating to a plant regulatory protein |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000499A1 Human fadd-interacting protein (fip) |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000497A1 Proteins capable of binding to corticotropin-releasing factor |
| 01/07/1999 | WO1999000496A1 Novel osteoclast differentiation promoting factor and its gene |
| 01/07/1999 | WO1999000495A1 Novel protein remarkably expressed in hepatic cancer, gene encoding the same, antibody thereto, and method for detecting the expression thereof |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1999000493A1 Tenebrio antifreeze proteins |
| 01/07/1999 | WO1999000492A1 Plant and viral promoters |
| 01/07/1999 | WO1999000491A1 Novel plasmid dna containing reporter gene dna and use of the same |
| 01/07/1999 | WO1999000490A2 Attenuated human immunodeficiency virus vaccine |
| 01/07/1999 | WO1999000424A2 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 01/07/1999 | WO1999000423A1 Protein that binds trail |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | WO1999000421A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | WO1999000419A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 01/07/1999 | WO1999000418A1 Anti-inflammatory peptides derived from c-reactive protein |
| 01/07/1999 | WO1999000417A1 Production of heparin-binding protein in mammalian cells |
| 01/07/1999 | WO1999000416A1 Use of heparin-binding protein for inhibiting entry of pathogens into mononuclear cells |
| 01/07/1999 | WO1999000415A1 Cardiotrophin-like cytokine |
| 01/07/1999 | WO1999000414A1 Chlamydia trachomatis specific peptides and their use in diagnostic assays |
| 01/07/1999 | WO1999000413A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 01/07/1999 | WO1999000412A1 Interferon stimulating protein and uses thereof |
| 01/07/1999 | WO1999000411A2 Two new wd-40 proteins |
| 01/07/1999 | WO1999000410A2 Human extracellular matrix proteins |
| 01/07/1999 | WO1999000409A1 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 01/07/1999 | WO1999000408A2 Human transmembrane protein from the transmembrane 4 superfamily |
| 01/07/1999 | WO1999000407A2 Improved bacillus thuringiensis toxin |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000405A1 Secreted proteins |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000403A1 Costal2 genes and their uses |
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |
| 01/07/1999 | WO1999000139A1 Antimicrobial agents from invertebrates |
| 01/07/1999 | WO1999000138A1 Methods and compounds for treating alzheimer's disease |